• Home
  • Topic
    • COVID-19
    • New Drugs
    • Oncology
    • Cardiology
    • Metabolism
    • Neuroscience
    • Autoimmune Diseases
    • Infections
    • Rare/Orphan Diseases
    • Drug Safety
  • Section
    • Pharma & Biotech
    • Regulatory
    • Clinical Trials
    • Mergers & Acquisitions
    • Research
    • In the Pipeline
  • BioPharma News
    • About Us
    • Our Team
    • Contact Us
    • Editorial Policy
    • Terms of Use
    • Privacy Policy
  • Subscribe
  • Facebook
  • Twitter
  • LinkedIn
  • Google News
Skip to content
  • Facebook
  • Twitter
  • LinkedIn
  • Google News
BioPharma News

BioPharma News

Biopharmaceutical industry analysis. Credible, reliable, equitable.

Subscribe
  • Home
  • Topic
    • COVID-19
    • New Drugs
    • Oncology
    • Cardiology
    • Metabolism
    • Neuroscience
    • Autoimmune Diseases
    • Infections
    • Rare/Orphan Diseases
    • Drug Safety
  • Section
    • Pharma & Biotech
    • Regulatory
    • Clinical Trials
    • Mergers & Acquisitions
    • Research
    • In the Pipeline
  • BioPharma News
    • About Us
    • Our Team
    • Contact Us
    • Editorial Policy
    • Terms of Use
    • Privacy Policy
  • Subscribe

Neuroscience

T cell.
Posted inAutoimmune Diseases, Clinical Trials, Neuroscience

Even Severe Multiple Sclerosis Can Be Cured

by Nik Resovski and Julia Mardi January 11, 2022September 8, 2022

Atara Biotherapeutics and its awesome T-cell therapy against Epstein–Barr virus can really cure progressive forms of multiple sclerosis.

brain
Posted inClinical Trials, Neuroscience

Buntanetap: Breakthrough in Treatment of Alzheimer’s and Parkinson’s

by Mark Gubar January 11, 2022September 8, 2022

Buntanetap acts simultaneously on three neurotoxic proteins responsible for neurodegenerative disorders: amyloid beta, alpha-synuclein, and tau protein.

insomnia
Posted inNeuroscience, New Drugs, Regulatory

Quviviq: New Sleeping Pill

by Tanya von Reuss January 10, 2022November 5, 2022

Daridorexant will help treat insomnia.

Posted inNeuroscience, Pharma & Biotech, Rare/Orphan Diseases

Biogen to Develop Updated Version of Spinraza

by Julia Mardi January 5, 2022September 8, 2022

Nusinersen for the treatment of spinal muscular atrophy will get a follow-up.

Biogen
Posted inMergers & Acquisitions, Neuroscience

Samsung Wants to Buy Biogen

by Alex Avisoni December 29, 2021September 8, 2022

The price tag is over $42 billion.

Posted inAutoimmune Diseases, Neuroscience, Oncology, Pharma & Biotech

Bit Bio: Mass and Problem-Free Production of Any Human Cells

by Tanya von Reuss November 11, 2021September 8, 2022

Human cells are needed for scientific research, development of new drugs, and creation of cell therapies.

Alltrna.
Posted inMetabolism, Neuroscience, Oncology, Pharma & Biotech, Rare/Orphan Diseases

Alltrna: World’s First Drugs Based on Transfer RNAs

by Tanya von Reuss November 9, 2021September 8, 2022

A completely new therapeutic modality will help treat both rare and common diseases.

Posts pagination

Newer posts 1 2 3 4 5 Older posts
BioPharma News Logo
Biopharmaceutical industry analysis.
© 2025 BioPharma News Powered by Newspack Privacy Policy
  • Facebook
  • Twitter
  • LinkedIn
  • Google News
BioPharma News

Awareness and enlightenment are strengths.

BioPharma News is an amazing and trustworthy non-profit data analysis service that provides honest and objective reporting on the Pharma & Biotech industry. We would like to invite you to sign up for our weekly Newsletter to stay informed and uptodate.

Please check your inbox or spam folder for an email from [email protected] to confirm your subscription.

×